Replies to post #5250 on Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

sorry about that, here's a repost of the potential catalysts that are most likely to affect ARIA in 2011:

Ponatinib partnering in Asia and/or EU
Start of AP113 Phase 1 trial
New Phase 3 ridaforolimus trials (P3 endometrial-single agent? P2 breast in combination with Merck's IGFR1 inhibitor, dalotuzumab??)
ASCO - first detailed look at SUCCEED data
possible first look at ponatinib data at ASH?
Ponatinib full enrollment
Filing rida NDA